相关实验视频
Updated: Jul 16, 2025

07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
23.3K
修改过敏原皮下免疫疗法的安全预防措施和减少系统性过敏反应的速度
Keren Mahlab-Guri1, David Mishayev2, Marina Yakovlev3
1Department of Allergy & Clinical Immunology, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
Immunotherapy
|September 11, 2023
概括
对皮下免疫疗法注射进行第二次检查,显著减少了全身过敏反应. 这种安全性增强对于患者的福祉和最大限度地减少免疫治疗副作用至关重要.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 临床医学 临床医学
- 患者安全 患者安全
背景情况:
- 皮下免疫疗法 (SCIT) 的医疗错误报告不足,尽管存在潜在的危及生命的反应.
- 据估计,剂量错误导致25%的SCIT相关系统反应.
- 关于SCIT期间医疗错误的频率和影响的数据有限.
研究的目的:
- 评估加强安全协议对SCIT系统性过敏反应 (SAR) 率的影响.
- 为了比较在实施强制性第二次过敏原检查之前和之后的SAR发生率.
主要方法:
- 追溯性比较队列研究设计.
- 分析了两个不同时期的SAR率:2012-2015年 (干预前) 和2016-2019年 (干预后).
- 干预措施包括在注射前由独立的医疗保健专业人员 (护士/医生) 进行注射过敏原的第二次验证.
主要成果:
- 在实施第二次检查后,每次注射的SAR率从0.93%降至0.71%.
- 这种减少在统计学上是显著的 (p = 0.023).
- 加强安全措施显然对SCIT期间的患者安全产生了积极影响.
结论:
- 另一个医疗保健专业人员的注射前验证步骤有效地降低了SAR率.
- 这种简单的安全增强可以改善SCIT患者的治疗结果.
- 标准化安全检查对于尽量减少免疫治疗中不良事件至关重要.
相关概念视频
Allergic Reactions
27.7K
Overview
27.7K
Allergic Drug Reactions
875
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
875
Hypersensitivities
730
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
730
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332
Cross-reactivity
31.2K
Overview
31.2K

